Rejected from International Journal of Biological Macromolecules? Where to Submit Next

Diagnose whether the decision is a scope, evidence, or reporting problem before selecting a new target.

A desk rejection usually gives the fastest signal about scope, article type, novelty, or the first-page presentation. Check the title, abstract, first figure, cover letter, and opening paragraph against the paper actually supported by the data. A paper on a synthetic polymer, a food product, a delivery vehicle, or a biological model may be valuable while still being a poor fit for a journal that expects the natural macromolecule itself to be central.

A post-review rejection is a technical worklist. Separate requests that alter the scientific record from requests that alter interpretation or presentation. Missing molecular-weight measurements, purity evidence, controls, sample replication, statistical reporting, mechanistic tests, or a fair comparator belong in the next manuscript. Do not solve an unresolved evidence problem by writing a more persuasive cover letter.

A transfer offer can reuse files and metadata. Elsevier states that the destination journal assesses the transferred submission. Read the recommendation as one input, not a verdict. Inspect the receiving journal's live aims, article type, access model, data policies, and whether the revised paper really answers its readers' question.

Day 1: preserve the full submitted record, label the decision as desk, post-review, or transfer, and make the evidence map. Do not open a new submission system while the reason for the decision is still vague.

Day 2: turn each editorial or reviewer point into a ledger with the requested change, the evidence needed, the person responsible, and the exact manuscript location. Mark each item as repair, explanation, or destination change.

Day 3: revise the title, abstract, first figure, methods summary, and conclusion together. Select one destination only when those components name the same macromolecule, contribution, evidence, limitation, and audience.

Carbohydrate Polymers

Best for: a polysaccharide-centered paper whose main contribution is polymer chemistry, modification, structure-property relationships, material behavior, or application performance grounded in the polymer evidence.

Think twice if: the biological macromolecule is only a carrier or additive, the decisive result is a food system, or the claim depends on biological function that has not been directly tested. Match the paper to the scientific object, not a shared material name.

Biomacromolecules

Best for: a manuscript that can establish a macromolecular mechanism, interaction, assembly, molecular design, or structure-function relationship with a complete and interpretable evidence chain.

Think twice if: the paper reports a broad panel of characterization measurements without a question that connects them, or if an application domain rather than the macromolecule is the reader's primary concern.

Food Hydrocolloids

Best for: a food-science manuscript in which the macromolecule's role in texture, rheology, stability, processing, sensory-relevant behavior, or a specific food matrix is central and tested.

Think twice if: a food example is being used to avoid a missing structure-function argument. Explain the matrix, processing conditions, comparator, and outcome that make the food-system result portable.

Process Biochemistry

Best for: work on biocatalysis, fermentation, extraction, purification, bioconversion, immobilization, or process conditions where the engineering and biochemical process question drives the manuscript.

Think twice if: process terminology merely reframes an uncharacterized material or a laboratory result without process controls, yield definitions, operating conditions, or reproducibility evidence.

International Journal of Pharmaceutics

Best for: a pharmaceutical formulation or delivery study where dosage form, release, stability, biological barrier, product performance, and the limitations of the model are directly demonstrated.

Think twice if: the manuscript offers only a nanoparticle or hydrogel characterization story with a therapeutic conclusion that has not been tested. The destination does not remove the need for formulation-relevant evidence.

An Elsevier transfer route

Best for: a manuscript with a real scope match to the suggested journal after the authors have reviewed its current aims, author guidance, article type, access model, and file requirements.

Think twice if: transfer is being used to carry the identical title, abstract, figures, and unresolved comments into a new editorial system. Convenience is not a routing rationale.

For every headline conclusion, name the supporting figure, raw data, sample or experimental unit, method, control, analysis choice, uncertainty, limitation, and audience. Where that chain ends in "may enable," either add the required evidence or narrow the claim.

1. Name the macromolecule precisely. Make the title, abstract, methods, figures, and conclusion agree about the molecular object and why it matters.
2. Make characterization answer a decision. Report the method, sample preparation, calibration, distribution, uncertainty, and limitation needed to establish identity or structural feature; do not present technique lists as evidence by themselves.
3. Test the proposed link. Distinguish structure, interaction, function, processing condition, and application outcome. Add controls that can challenge the preferred explanation.
4. State the experimental unit. Report biological or material replicates, independent preparations, exclusions, statistical method, and what variability the error display represents.
5. Use a matched comparator. Compare molecular weight, composition, concentration, solvent, pH, ionic strength, temperature, processing history, assay conditions, and time scale where those conditions change the conclusion.
6. Expose the boundary. Show when the result stops holding: composition range, processing condition, matrix, model system, dose, storage, or sample source.
7. Rebuild the manuscript components together. Align title, abstract, introduction, figure sequence, captions, methods, results, discussion, supplementary files, data statement, and cover letter around the revised evidence chain.
8. Check the new journal live. Aims, article type, prior-publication policy, access option, data requirements, and formatting rules can change. Confirm them before upload.

Audit whether the macromolecule, characterization, functional evidence, and target-journal fit make one defensible record.

Appeal only when a specific factual or procedural error could plausibly change the decision. For example, identify the reviewer claim, the named figure or method that corrects it, why the correction matters, and the requested remedy. A general disagreement about novelty, priority, scope, or taste is normally better handled through revision and a better-matched destination.

Accept a transfer only after verifying the destination's fit and deciding what needs revision. A transfer offer can reduce administrative effort, but it does not replace the receiving editor's assessment and does not make reviewer concerns disappear.

Use a fresh submission when the revised manuscript is clearly a polymer, food, process, formulation, or molecular-mechanism paper with a new reader job. Close the prior process and never submit the same manuscript to another journal in parallel.

In our pre-submission review work with International Journal of Biological Macromolecules candidates, we trace the named macromolecule from the title through source material, purification, characterization, functional evidence, controls, comparator, limitation, and conclusion. These are manuscript patterns, not claims about private editorial decisions or acceptance probability.

Pattern 1: the macromolecule is a material ingredient, not the scientific subject

In IJBM candidates, a chitosan, cellulose, protein, or polysaccharide can appear throughout the manuscript while the real novelty is a composite, coating, processing step, or device metric. We compare the title and abstract with the synthesis, molecular-weight evidence, structural characterization, and principal figures. When the macromolecule does not organize the argument, the repair may be a different journal and a more honest manuscript frame rather than additional biomacromolecule language.

Pattern 2: characterization accumulates without resolving the claim

Another International Journal of Biological Macromolecules pattern is a dense suite of FTIR, NMR, XRD, microscopy, thermal, or rheological measurements that does not establish the specific structural feature needed for the conclusion. We ask what each method can and cannot identify, whether calibration and sample preparation are clear, and whether molecular weight, purity, substitution, conformation, or distribution is actually supported. The right response may be one decisive measurement, a narrower conclusion, or a journal whose reader job is material performance rather than molecular mechanism.

Pattern 3: function and application are ahead of the evidence

IJBM manuscripts often connect a material property to bioactivity, delivery, food performance, or a health consequence without a test that distinguishes competing explanations. We map concentration, controls, assay choice, matrix, model, replication, and the claimed mechanism. A revised paper can become stronger by adding the discriminating experiment; it can also become more credible by limiting the claim to the measured material behavior and choosing the field that values that result.

Pattern 4: a fair comparison changes the destination

The final recurring pattern compares a modified macromolecule with a prior material under different molecular weight, composition, pH, ionic strength, concentration, processing history, or assay conditions. We rebuild the comparison table around matched conditions, identify the experimental unit, and make uncertainty visible. Sometimes the corrected result remains a biomacromolecule story. Sometimes it belongs to a food, polymer, process, or formulation audience. That is useful routing information, not a failed resubmission.

Choose the next journal only after the revised abstract can name the macromolecule, contribution, method, comparator, functional or application evidence, limitation, and reader. Verify the destination's live scope and policies before uploading.

After indexation, record exact-owner impressions, clicks, query fit, and qualified readiness starts at 14 complete GSC days. At 21 complete days, keep, revise, consolidate, or stop this owner based on observed demand and conversion fit.